Hemophilia Federation of America is pleased to announce Dateline LIVE: Navigating Approved Products and Emerging Therapies.
Annually, we’ve compiled a comprehensive list of therapies approved by the Food and Drug Administration as well as all investigational therapeutic products undergoing clinical trial and have published that list in a special issue of our quarterly magazine Dateline Federation. This year, we are bringing this special issue to life as we launch Dateline LIVE.Â
Join Us
This three-day, online event will help patients and caregivers with daunting responsibility of navigating available treatment options and emerging therapies.Â
Wednesday, June 23 | 4pm – 8:15pm
- Welcome by Sharon Meyers
- Product Informational Session by Genentech, CSL Behring, Sanofi Genzyme
- Break
- Shared Decision Making: Making the Most of the Patient/Provider Relationship
- Rap Session
Thursday, June 24 | 4pm – 8:15pm
- Bleeding Disorders Alphabet Soup: What Do These Mean
- Product Informational Session by HEMA Biologics and Sanofi Genzyme
- Break
- What to Expect When Participating in Clinical Trials
- Rap Session
Friday, June 25 | 4pm – 6:45pm
- Get Counted: The Importance of Registries
- Emerging Therapies: The Latest in Clinical Trials
- Final Word by Sonji Wilkes
Thank you to our Sponsors
